Regional Home Health Agencies Are Quietly Exiting Medicare Advantage Contracts
When the Contract Math Stops Working
Home health agencies built their businesses around Medicare Advantage the same way small retailers once built around mall traffic – it seemed like the stable, high-volume channel that would sustain growth indefinitely. That calculus has shifted. Across the country, regional home health operators are quietly declining to renew Medicare Advantage contracts, or in some cases, terminating them mid-cycle. The exits are not dramatic announcements. They happen through non-renewal letters, internal memos to staff, and slow patient transitions – the kind of organizational decisions that rarely make headlines but reshape how millions of older Americans access care at home.
The reasons are not mysterious. Medicare Advantage plans have tightened prior authorization requirements, slowed reimbursement timelines, and in many markets, held rates flat while operational costs – labor above all – have climbed. For a large national agency, those pressures are manageable with scale and contract leverage. For a regional operator serving two or three counties with a staff of fifty, they can render a contract financially unsustainable within a single fiscal year.
The Prior Authorization Problem
Prior authorization is where the relationship between home health agencies and Medicare Advantage plans most visibly breaks down. Traditional Medicare does not require prior authorization for home health services if a physician certifies medical necessity. Medicare Advantage plans do – and the criteria they apply, the timelines they impose, and the rates at which they deny or delay approvals vary dramatically from plan to plan and, in some cases, from month to month within the same plan. For a regional agency managing dozens of active patients, each authorization represents administrative labor with no guaranteed reimbursement at the end of it.
That administrative burden compounds over time. Agencies assign staff specifically to manage authorization workflows – submitting documentation, following up on pending approvals, appealing denials. None of that work is billable. It comes directly out of operating margin. When a plan’s denial rate climbs, or when approvals that previously came within 48 hours start taking two weeks, the agency is effectively subsidizing the plan’s utilization management process. At some point, the contract stops generating profit and starts generating overhead.
Rate Structures That No Longer Cover Costs
Home health reimbursement under Medicare Advantage is negotiated, not standardized. That sounds like an opportunity – agencies can theoretically negotiate better rates with high-performing plans – but in practice, regional operators rarely have the leverage to push rates meaningfully above what plans are willing to offer. Large national chains with patient volume can extract better terms. A regional agency covering a mid-sized metro area cannot credibly threaten to walk away from a plan that covers a third of the local Medicare population.
Labor costs have restructured the math entirely. Home health aides and skilled nursing staff earn more than they did three years ago, and turnover remains high enough that recruiting costs are a persistent line item rather than an occasional expense. When a Medicare Advantage contract was negotiated in a labor environment that looked nothing like today’s, the rate locked in then may not come close to covering what it costs to deliver the same visit now.
Some agencies have tried to renegotiate. The results are mixed at best. Plans have their own margin pressures – medical loss ratios, broker fees, the cost of managing an aging member population – and they have limited appetite for rate increases with a regional provider they could theoretically replace. That asymmetry of leverage is the core of the problem. The agency needs the contract more than the plan needs the agency, until the agency decides it doesn’t.
The decision to exit is rarely clean. Patients enrolled in Medicare Advantage plans who rely on the agency for skilled nursing visits or therapy services have to be transitioned to other providers – if other providers exist and have capacity. In rural and semi-rural markets, that transition may not be possible without gaps in care. Some agencies cite patient continuity as the reason they stayed in contracts longer than the economics justified. The liability of abandoning patients is real, and it slows the exit even when the financial case is clear.
What This Means for Medicare Advantage Enrollees
Medicare Advantage enrollment has grown steadily for years, and insurers have marketed the plans aggressively as superior to traditional Medicare. For many beneficiaries, the plans do offer real benefits – dental, vision, lower premiums. But the value proposition depends on a functioning provider network, and home health is a category where network adequacy has become a genuine question. When regional agencies exit, the plans must either find replacement providers – often at higher cost, or with longer travel times – or narrow the effective benefit.
Beneficiaries often don’t discover network gaps until they need care. A patient discharged from a hospital who requires skilled nursing at home may find that the agency they used previously no longer accepts their plan, and that the plans in-network options have waiting lists or don’t serve their zip code. That gap between the marketed benefit and the delivered benefit is where patient harm occurs – quietly, without public accounting.
The Regional Consolidation Pressure
Agency exits from Medicare Advantage contracts are accelerating another trend already underway: consolidation. When a regional operator concludes that the Medicare Advantage book of business is not worth maintaining, it faces a strategic choice – convert to a traditional Medicare-only model, sell to a larger operator that has better contract terms, or close. All three outcomes reduce the number of independent regional agencies in the market.
Larger operators – national chains, private equity-backed platforms – are acquiring regional agencies in part because they can renegotiate the Medicare Advantage contracts that defeated the smaller operator. Scale changes the leverage equation. A chain operating in twenty markets can credibly threaten network withdrawal in a way a two-county regional shop cannot. This dynamic is similar to what is playing out in other healthcare specialties, including regional dermatology practices being acquired by private equity groups – the independent operator becomes unviable, and the asset gets absorbed.
What gets lost in consolidation is harder to quantify than what gets gained. Regional agencies often have deep relationships with local hospital discharge planners, familiarity with specific patient populations, and staff continuity that produces better outcomes. A national operator running a standardized care model across hundreds of locations may hold better contracts but deliver a different – and not necessarily better – product. Whether that trade-off serves patients or just the balance sheet is a question the industry has not resolved, and regulators have not yet been forced to answer.
For Medicare Advantage plans, the wave of regional exits creates a network problem they cannot solve purely through rate adjustments. The agencies that are leaving are not bluffing for better terms – many of them are genuinely done. And in markets where only one or two regional operators existed, replacing them means either attracting new entrants who face the same cost pressures, or contracting with large national providers whose terms are far less favorable to the plan. The plans built their growth story on the assumption that providers would absorb the friction. Some of them are no longer willing to.
